2025
SJR Q2
JCR Q2 · 3
29 eşleşen makale
SCIE
Dergi ayrıntısı
International Clinical Psychopharmacology
- Yayıncı
- Lippincott Williams and Wilkins
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
0268131514735857
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,781
- Quartile Q2
- H-Index 102
- Atıf/yayın 2,23
- Doküman (3y) 163
- Atıf (3y) 379
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3
- 5Y JIF 2,5
- JCI 0,72
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Pharmacology (medical) Q2
- Psychiatry and Mental Health Q2
Alanlar
- Medicine
WoS kategorileri
- Pharmacology & Pharmacy | Psychiatry
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,781 | 3 | 2,5 | 0,72 | Q2 | 102 |
| 2024 | Q2 | Q2 | 0,642 | 2,5 | 2,1 | 0,7 | Q2 | 100 |
| 2023 | Q2 | Q3 | 0,621 | 2,1 | 1,8 | 0,64 | Q3 | 100 |
| 2022 | Q2 | Q3 | 0,672 | 2,6 | 2 | 0,54 | Q3 | 100 |
| 2021 | Q2 | Q4 | 0,521 | 2 | 2,1 | 0,44 | Q3 | 100 |
| 2020 | Q2 | Q4 | 0,559 | 1,7 | 2,1 | 0,49 | Q3 | 100 |
| 2019 | Q2 | Q3 | 0,799 | 1,7 | 2,4 | 0,63 | Q3 | 100 |
| 2018 | — | Q3 | — | 1,6 | 2,2 | 0,81 | Q2 | — |
| 2017 | Q1 | Q3 | 1,086 | 2,3 | 2,3 | 1,02 | Q1 | 100 |
| 2016 | Q1 | Q2 | 1,097 | 3 | 2,7 | — | — | 100 |
| 2015 | Q1 | Q2 | 1,048 | 2,4 | 2,8 | — | — | 100 |
| 2014 | Q1 | Q2 | 1,003 | 2,5 | 2,8 | — | — | 100 |
| 2013 | Q1 | Q2 | 1,248 | 3,1 | 3,2 | — | — | 100 |
| 2012 | Q1 | Q2 | 1,219 | 2,7 | 3 | — | — | 100 |
| 2011 | Q1 | Q2 | 1,16 | 2,9 | 3,1 | — | — | 100 |
| 2010 | Q1 | Q2 | 1,373 | 2,8 | 3,3 | — | — | 100 |
| 2009 | — | Q2 | — | 3,3 | 3,2 | — | — | — |
| 2008 | — | Q2 | — | 2,9 | 2,9 | — | — | — |
| 2007 | — | Q1 | — | 3,3 | 3,4 | — | — | — |
| 2006 | — | Q2 | — | 3,1 | — | — | — | — |
| 2005 | — | Q2 | — | 2,7 | — | — | — | — |
| 2004 | — | Q1 | — | 3,1 | — | — | — | — |
| 2003 | — | Q1 | — | 3 | — | — | — | — |
| 2002 | — | Q1 | — | 2,8 | — | — | — | — |
| 2001 | — | Q1 | — | 2,3 | — | — | — | — |
| 2000 | — | Q2 | — | 2,1 | — | — | — | — |
| 1999 | — | Q3 | — | 1,1 | — | — | — | — |
| 1998 | — | Q2 | — | 1,6 | — | — | — | — |
| 1997 | — | Q1 | — | 1,9 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 169/356 |
| 2025 | PSYCHIATRY | SCIE | Q2 | Q2 | 112/293 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 181/352 |
| 2024 | PSYCHIATRY | SCIE | Q2 | Q3 | 130/288 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 210/354 |
| 2023 | PSYCHIATRY | SCIE | Q3 | Q3 | 148/279 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 183/278 |
| 2022 | PSYCHIATRY | SCIE | Q3 | Q3 | 108/155 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 232/279 |
| 2021 | PSYCHIATRY | SCIE | Q4 | Q3 | 133/155 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 241/276 |
| 2020 | PSYCHIATRY | SCIE | Q4 | Q3 | 132/156 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 217/271 |
| 2019 | PSYCHIATRY | SCIE | Q3 | Q3 | 111/155 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q2 | 207/267 |
| 2018 | PSYCHIATRY | SCIE | Q3 | Q2 | 103/146 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q1 | 150/261 |
| 2017 | PSYCHIATRY | SCIE | Q3 | Q2 | 74/142 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 90/257 |
| 2016 | PSYCHIATRY | SCIE | Q2 | — | 55/142 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 122/255 |
| 2015 | PSYCHIATRY | SCIE | Q2 | — | 65/142 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 120/255 |
| 2014 | PSYCHIATRY | SCIE | Q2 | — | 62/140 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 69/256 |
| 2013 | PSYCHIATRY | SCIE | Q2 | — | 45/136 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 95/261 |
| 2012 | PSYCHIATRY | SCIE | Q2 | — | 54/135 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 82/261 |
| 2011 | PSYCHIATRY | SCIE | Q2 | — | 44/130 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 88/252 |
| 2010 | PSYCHIATRY | SCIE | Q2 | — | 46/128 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 61/237 |
| 2009 | PSYCHIATRY | SCIE | Q2 | — | 38/117 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 71/219 |
| 2008 | PSYCHIATRY | SCIE | Q2 | — | 37/101 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 51/205 |
| 2007 | PSYCHIATRY | SCIE | Q2 | — | 28/94 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 52/199 |
| 2006 | PSYCHIATRY | SCIE | Q2 | — | 29/94 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 55/193 |
| 2005 | PSYCHIATRY | SCIE | Q2 | — | 33/94 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 44/187 |
| 2004 | PSYCHIATRY | SCIE | Q1 | — | 22/90 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 39/185 |
| 2003 | PSYCHIATRY | SCIE | Q2 | — | 22/87 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 42/188 |
| 2002 | PSYCHIATRY | SCIE | Q2 | — | 25/88 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 43/186 |
| 2001 | PSYCHIATRY | SCIE | Q2 | — | 26/81 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 50/181 |
| 2000 | PSYCHIATRY | SCIE | Q2 | — | 25/82 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 96/175 |
| 1999 | PSYCHIATRY | SCIE | Q3 | — | 46/80 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 60/178 |
| 1998 | PSYCHIATRY | SCIE | Q2 | — | 26/77 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 38/157 |
| 1997 | PSYCHIATRY | SCIE | Q2 | — | 20/67 |